A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL

被引：47

作者：

Best, O. G. ^{[1
]}

Gardiner, A. C. ^{[1
]}

Majid, A. ^{[2
]}

Walewska, R. ^{[2
]}

Austen, B. ^{[3
]}

Skowronska, A. ^{[3
]}

Ibbotson, R. ^{[1
]}

Stankovic, T. ^{[3
]}

Dyer, M. J. S. ^{[2
]}

Oscier, D. G. ^{[1
]}

机构：

[1] Royal Bournemouth Hosp, Bournemouth, Dorset, England

[2] MRC, Toxicol Unit, Leicester, Leics, England

[3] Univ Birmingham, Div Canc Studies, Birmingham, W Midlands, England

来源：

LEUKEMIA | 2008年 / 22卷 / 07期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/sj.leu.2405092

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1456 / 1459

页数：4

共 8 条

[1] Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL [J].

Austen, B ;

Powell, JE ;

Alvi, A ;

Edwards, I ;

Hooper, L ;

Starczynski, J ;

Taylor, AMR ;

Fegan, C ;

Moss, P ;

Stankovic, T .

BLOOD, 2005, 106 (09) :3175-3182

[2] Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion [J].

Austen, Belinda ;

Skowronska, Anna ;

Baker, Claire ;

Powell, Judith E. ;

Gardiner, Anne ;

Oscier, David ;

Majid, Aneela ;

Dyer, Martin ;

Siebert, Reiner ;

Taylor, A. Malcolm ;

Moss, Paul A. ;

Stankovic, Tatjana .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) :5448-5457

[3] p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia [J].

Bromidge, T ;

Lowe, C ;

Prentice, A ;

Johnson, S .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :223-229

[4] Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: Justification for risk-adapted therapy [J].

Byrd, JC ;

Gribben, JG ;

Peterson, BL ;

Grever, MR ;

Lozanski, G ;

Lucas, DM ;

Lampson, B ;

Larson, RA ;

Caligiuri, MA ;

Heerema, NA .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :437-443

[5] Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia [J].

Carter, A ;

Lin, K ;

Sherrington, PD ;

Atherton, M ;

Pearson, K ;

Douglas, A ;

Burford, A ;

Brito-Babapulle, V ;

Matutes, E ;

Catovsky, D ;

Pettitt, AR .

LEUKEMIA, 2006, 20 (04) :737-740

[6] Detection of p53 dysfunction by flow cytometry in chronic lymphocytic leukaemia [J].

Carter, A ;

Lin, K ;

Sherrington, PD ;

Pettitt, AR .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (04) :425-428

[7]

JONES GG, 2005, LEUK LYMPHOMA S1, V46, pS56

[8]

Oscier DG, 2006, BLOOD, V108, p92A

← 1 →